Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001562180-21-005284

Chief Financial Officer acquired 26,892 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reine Allan Chief Financial Officer 2021-08-09 Option exercise +26,892 $3.72 $100,038 53,784 D
Derivatives
Reine Allan Chief Financial Officer 2021-08-09 Option exercise · Stock Options (Right to buy) +26,892 257,512 D
Loading xslF345X03/primarydocument.xml…